# Bain Capital and Cinven to acquire Lonza Specialty Ingredients for CHF 4.2B

Bain Capital Private Equity and Cinven have entered into definitive agreements to acquire Lonza Specialty Ingredients, a division of Lonza AG, for a total enterprise value of CHF 4.2 billion.

- Type: Acquisition
- Announced: 2021-02-08
- Where: Basel, Switzerland, Switzerland
- Value: $4.60B (4.20B CHF)
- Status: announced
- Products: microbial control solutions, specialty chemicals
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [Bain Capital Private Equity](https://endata.com/companies/1255.md) (acquirer)
- [Lonza Group AG](https://endata.com/companies/20735.md) (target)
- [Cinven](https://endata.com/companies/23050.md) (acquirer)

## Sources

- [cinven.com](https://www.cinven.com/news-insights/bain-capital-private-equity-and-cinven-enter-into-definitive-agreements-to-acquire-lonza-specialty-ingredients/), 2021-02-08: "Bain Capital Private Equity and Cinven have entered into definitive agreements to acquire Lonza Specialty Ingredients, a division of Lonza AG, for a total enterprise value of CHF 4.2 billion."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.